A Single Arm, 12 Week, Multicentre, Open Label, Phase IV Study to Evaluate Correct Use of and Patient Satisfaction From Sequential Use of Formoterol and Budesonide Inhaler Capsules Via Aerolizer Device in Patients With Asthma.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 26 Apr 2017
At a glance
- Drugs Budesonide; Formoterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Novartis Pharmaceuticals
- 04 Oct 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 28 Oct 2009 New trial record